Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Prospective, Open-Label, Randomized Study of Combination Therapy of MYOCET® Plus Cyclophosphamide and Trastuzumab Versus Free Doxorubicin Plus Cyclophosphamide Alone, Each Followed by Docetaxel and Trastuzumab, in Neoadjuvant Setting in Treatment-Naïve Patients With HER2-Positive Breast Cancer https://www.kusajili.fr:443/Trial/BgXSJlFhz0CqoD8JAI0Y8w%24prospective-open-label-randomized-study-of-combination-therapy-of-myocetr-plus-cyclophosphamide-and-trastuzumab-versus-free-dox
I have read and accept the terms of use of the site and the Privacy Policy
Send your message